Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.
about
The role of prostaglandins in allergic lung inflammation and asthmaRegulation of vascular smooth muscle tone by adipose-derived contracting factorProstaglandins, bioassay and inflammationEighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclinThromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxidesDetection and isolation of an endoperoxide intermediate in prostaglandin biosynthesisIsolation and structure of two prostaglandin endoperoxides that cause platelet aggregationThe influence of environmental agents on prostaglandin biosynthesis and metabolism in the lung. Inhibition of lung 15-hydroxyprostaglandin dehydrogenase by exposure of guinea pigs to 100 per cent oxygen at atmospheric pressureHistamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acetherThe platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotrieneRole of platelets in aspirin-sensitive bronchoconstriction in the guinea-pig; interactions with salicylic acid.Salicylic acid prevents inhibition by aspirin of arachidonic acid-induced hypotension, bronchoconstriction and thrombocytopenia [proceedings]Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.Nonsteroidal anti-inflammatory drugs: a review. New applications in hypersensitivity reactions of cattle and horses.The history of mast cell and basophil research - some lessons learnt from the last century.Effect of indomethacin in asthma: evidence against a role for prostaglandins in its pathogenesis.Effects of the 15-methyl analogs of prostaglandins E2 and F2alpha on the pulmonary circulation in the intact dog.Adventures in vascular biology: a tale of two mediators.Effects of cigarette smoking on metabolic events in the lungEffects of bradykinin and indomethacin on cyclic GMP and cyclic AMP in lung slices.Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.Mechanism and modification of bradykinin-induced coronary vasodilationRole of magnesium in Escherichia coli alkaline phosphataseInhibitory effects of aprotinin on kallikrein and kininases in dog's blood.A dual action of histamine on guinea-pig lung vesselsComparative bioassay of prostaglandin E2 and its three pulmonary metabolites.Mediators of passive lung anaphylaxis in the rat.Some pharmacological effects of p-chlorophenylalanine unrelated to tryptophan hydroxylase inhibition.Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid.Bioassay and thin-layer chromatography of prostaglandins and their pulmonary metabolites [proceedings].Heterogeneity of inhibitory mechanisms in the nucleus accumbens and preoptic area of the [proceedings]Potentiation of angiotensin II-induced natriuresis by indomethacin in the rat [proceedings].Inhibition by glucocorticoids of prostaglandin release from adipose tissue in vitro.Prostaglandin uptake and metabolism by the perfused rat liver.Cutaneous reactions to intradermal prostaglandinsAcute systemic anaphylaxis in the calf.Some effects of burimamide on the isolated perfused pulmonary circulation of the guinea-pigProceedings: Evidence for a dopaminergic mechanism for modulation of adrenergic transmission in the rabbit ear artery.The release of spasmogenic substances from human chopped lung tissue and its inhibition.
P2860
Q27024735-FE501403-0FC0-4D17-930F-ECB6920D317DQ27302891-B559E489-5AB3-4ECE-8ABC-6A7ABA5D855DQ28194428-AB6B2BBE-DC64-440A-9966-ED200A58FCC8Q28277612-B918C882-458B-45C1-B6ED-06D339780619Q28619497-EDAD4F78-E55D-4998-8BE9-5543AF7CBC5CQ28622625-A5046B99-80B8-44D0-AAA1-44B84D6BCC6FQ28622645-F314F4B4-5A5F-4CF9-9624-C5BC19B66D48Q33435416-6E67700C-DDD5-4348-8466-981B78958095Q33459605-2EA8342E-6DF9-4C43-9236-4624E2DE6C48Q33478300-BAC3AAC6-D209-419F-ABA8-ED1CD89A0EB8Q33478655-ED91049D-D6C5-467E-8A77-520E7976E6ACQ33496863-7E921D5C-4C43-483A-80D8-AB395FEC0D3BQ33688695-193A35CA-F774-45E2-8886-496EE7FFD363Q34119413-5F0BA5C6-2B8C-4376-A3CD-8A676C7B2A90Q34367655-76275B08-1360-4125-8426-11BA47DADF31Q34451700-1755D1D2-24A3-4DBD-96AB-9C2CE612BCADQ34477987-FAC6DD24-56F7-4920-A71A-DF28B7683F6BQ34515584-CF74B707-9C1E-44FD-B20A-E99572142CA8Q34661179-8D04F7DA-7F76-4955-B30B-2229C11F44D4Q34752607-011A0414-4B2D-452B-B35F-2AA6989FFAACQ35020372-FB8873DE-1B1D-48F4-83A3-AE0C1B96F600Q35052870-B4BA6022-FCEF-4F95-A444-CCAA0E5CC844Q35080604-24BF4511-B0CE-4C73-B370-B63E1C8691E8Q35085069-3213A72B-3AD7-4FD3-B28A-417EF1780422Q35173993-0FA3DE82-81D2-4411-97A9-DD2A6A52DD7AQ35174554-52B2F6C1-E4B3-4A88-8EFD-AF34F101324DQ35175100-BDFA7478-7F8F-40AF-94DE-A168733D8803Q35175469-84EF40D6-3FCD-489A-B838-61E89358A797Q35175651-61E14291-6E4E-40CA-8F83-10C75A6A463DQ35176237-58144057-B82F-4C83-BC7F-BD033BE91831Q35176323-0F58E514-4C04-4C12-9DAE-D00EF48E4B7EQ35176460-429735FF-A59F-4EC6-82E2-6ECDD241C8C2Q35177345-0B2323E3-E91B-4CA8-9864-BD03C23FB3B4Q35177361-E4774767-7DAC-4EE8-92F8-F779406C78B9Q35225808-4595CAD0-CEE1-4F66-866D-C30E92774F7EQ35225985-39A0F823-0071-495F-9EE7-CF69BD2413D6Q35600429-5410733A-90C0-4F4B-90C1-BC5ACC4FF3DDQ35600542-F9F6CF2C-85D0-4A3D-BAF7-F411899000B2Q35600619-4FDD0CB7-D005-4FCC-8D1C-33E69815232AQ35600788-D8C770DB-2C98-4DDA-B3E8-6B93FFB915E2
P2860
Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh-hant
name
Release of additional factors ...... sm by anti-inflammatory drugs.
@en
Release of additional factors ...... sm by anti-inflammatory drugs.
@nl
type
label
Release of additional factors ...... sm by anti-inflammatory drugs.
@en
Release of additional factors ...... sm by anti-inflammatory drugs.
@nl
prefLabel
Release of additional factors ...... sm by anti-inflammatory drugs.
@en
Release of additional factors ...... sm by anti-inflammatory drugs.
@nl
P2860
P356
P1433
P1476
Release of additional factors ...... sm by anti-inflammatory drugs.
@en
P2093
P2860
P2888
P356
10.1038/223029A0
P407
P577
1969-07-01T00:00:00Z
P6179
1001672894